Results 81 to 90 of about 3,339 (149)

Efficacy and safety of twice- or thrice-weekly dutasteride versus daily finasteride in men with androgenetic alopecia: A randomized, investigator-blinded, active-controlled, parallel-group pilot study. [PDF]

JAAD Int
Sereepanpanich V, Khunkhet S, Rojhirunsakool S, Udompataikul M.   +3 more
europepmc   +1 more source

Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. [PDF]

Front Pharmacol
Torres de Souza G, Williams G, Vicente Silva CC, Chiovatto CB, Epstein GK, Vila-Vecilla L, Russo V.   +6 more
europepmc   +1 more source

SRY mediates male-specific susceptibility to acute liver injury. [PDF]

Cell Commun Signal
Ke MY, Fang Y, Wei SS, Li N, Dai LZ, Zhang XG, Wu RQ, Lyu Y, Zhang XF, Dong J.   +9 more
europepmc   +1 more source

Body mass index as a potential confounder in dutasteride and fertility studies. [PDF]

Clin Exp Reprod Med
Akbari AR, Alam B, Ageed A.
europepmc   +1 more source

Pim1 Serves as a Therapeutic Target for Inflammatory Arthritis via Mitochondrial Metabolism and Th17 Cell Differentiation. [PDF]

Research (Wash D C)
Su Z, Zeng Y, Li Q, Li J, Zheng G, Zhang W, Xiao Z, Chen Z, Lin Y, Liu Z, Wu Y, Lin J, Yu W, Xie Z.   +13 more
europepmc   +1 more source

Association between insulin resistance and prostate volume: A 4-year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. [PDF]

BJUI Compass
Daniels JP, Hernández-Tirado A, Mirocha J, Zheng R, Palmer J, Moreira D, Freedland SJ.   +6 more
europepmc   +1 more source

A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia. [PDF]

Cureus
Panuganti VK, Kumar Madala P, Ramalingayya Grandhi V, Varma Alluri C, Mohammad J, Rao Kssvv S, Reddy Dundigalla M.   +6 more
europepmc   +1 more source

Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. [PDF]

Ann Dermatol
Lee S, Kim JE, Lew BL, Huh CH, Kim J, Kwon O, Kim MB, Lee YW, Lee Y, Park J, Kim S, Kim DY, Choi GS, Kang H.   +13 more
europepmc   +1 more source

Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study. [PDF]

Dermatol Ther (Heidelb)
Cedirian S, Pampaloni F, Quadrelli F, Rapparini L, Bruni F, Martelli G, Piraccini BM, Starace M.   +7 more
europepmc   +1 more source

Th,-e mechanistic insights into the application of retinoids and possible adjunct therapeutic treatment to androgenic alopecia. [PDF]

Ann Med Surg (Lond)
Irfan H, Raza AA, Chowdhry HA, Mobin MB, Samadi A.   +4 more
europepmc   +1 more source